Blog

Trophy State. Valued Input. Optimism. Teamwork.

Jeff Patton, MD, Tennessee Oncology, CEO, OneOncology, President of Physician Services Happy fall everyone. I know, I know, I just can’t help myself. Every year come spring, I say I love spring the best and then come fall I declare my love for fall. Surely I’m not alone in this seasonal inconsistency. But one thing […]

Read More

New cancer care company lands $200M from former Emdeon owner

Tennessee Oncology one of three practices at heart of ambitious community care venture A new oncology company comprising Tennessee Oncology and two other practices has landed $200 million in funding with the goal of pushing high-level cancer care into more communities. OneOncology is being led by former CVS Health executive and Emdeon Chairman Tracy Bahl […]

Read More

Equity firm invests $200 million to launch Nashville oncology company

Three oncology practices from across the country have joined forces with a private investor and tech firm to launch a separate Nashville-headquartered company. Connecticut-based General Atlantic has invested $200 million to launch OneOncology, a company designed to help community oncology practices with technology, data, research and innovation by leveraging its scale. Nashville-based Tennessee Oncology, New […]

Read More

General Atlantic Takes Majority Stake in OneOncology, a Startup for Running Cancer-Doctor Practices

$200 million deal by private-equity firm is latest sign investors see opportunity in the health-services sector By Melanie Evans Sept. 12, 2018 12:03 a.m. ET Private-equity firm General Atlantic has agreed to invest $200 million in a startup that aims to manage independent cancer-treatment clinics, the latest sign investors see opportunity in the health-services sector. […]

Read More

Sarah Cannon Promotes William Donnellan, MD, to Director, Leukemia/Myelodysplastic Syndrome Research

NASHVILLE, TENN., May 30, 2018 – Today, Sarah Cannon announced the promotion of William Donnellan, MD, to Director of Leukemia/Myelodysplastic Syndrome (MDS) Research in Nashville. Since joining Sarah Cannon in 2014, Dr. Donnellan has served as an investigator of hematologic malignancies, specializing in treating patients with a variety of blood cancers. “Dr. Donnellan has played […]

Read More